|

Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery

RECRUITINGN/ASponsored by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Actively Recruiting
PhaseN/A
SponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Started2026-05-16
Est. completion2026-10-25
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07588230

Summary

This randomized, double-blind, placebo-controlled study aims to evaluate the effect of the serratus posterior superior intercostal plane (SPSIP) block on postoperative pain and opioid consumption in patients undergoing minimally invasive cardiac valve surgery via mini-thoracotomy.

Eligibility

Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Adult patients aged 18-75 years
* ASA physical status I-III
* Scheduled for elective minimally invasive cardiac valve surgery via mini-thoracotomy
* Able to understand and use the Numeric Rating Scale (NRS)
* Provided written informed consent

Exclusion Criteria:

* Age \>75 years
* Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine)
* Coagulopathy or ongoing anticoagulant therapy that cannot be discontinued
* Infection at the planned block site
* Chronic opioid use or chronic pain conditions
* Severe pulmonary disease affecting respiratory assessment
* Neurological or psychiatric disorders interfering with pain assessment
* Emergency surgery
* Pregnancy or breastfeeding
* Refusal to participate

Conditions3

Heart DiseaseHeart Valve DiseasePostoperative Pain

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.